Cargando…
Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction
INTRODUCTION: The amount and duration of opioids necessary after anterior cruciate ligament reconstruction (ACLR) are inadequately defined. This study sought to prospectively (1) define the amount and duration of opioid consumption, (2) investigate the relationship between preoperative pain expectat...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759619/ https://www.ncbi.nlm.nih.gov/pubmed/35025832 http://dx.doi.org/10.5435/JAAOSGlobal-D-21-00298 |
_version_ | 1784633138308186112 |
---|---|
author | Sayegh, Eli T. Otto, Tracey S. Garvey, Kirsten D. Martin, Anna Lowenstein, Natalie A. Matzkin, Elizabeth G. |
author_facet | Sayegh, Eli T. Otto, Tracey S. Garvey, Kirsten D. Martin, Anna Lowenstein, Natalie A. Matzkin, Elizabeth G. |
author_sort | Sayegh, Eli T. |
collection | PubMed |
description | INTRODUCTION: The amount and duration of opioids necessary after anterior cruciate ligament reconstruction (ACLR) are inadequately defined. This study sought to prospectively (1) define the amount and duration of opioid consumption, (2) investigate the relationship between preoperative pain expectation and postoperative satisfaction with pain management, and (3) identify risk factors for increased opioid use after ACLR. METHODS: One hundred eight patients undergoing primary ACLR with hamstring graft were prospectively analyzed for preoperative pain expectation, using visual analog scale (VAS) rating, and postoperative satisfaction with pain management. Univariate and multivariate analyses were done to identify patient characteristics associated with satisfaction and/or amount and duration of opioid use. RESULTS: Mean duration and cumulative intake of opioid consumption after ACLR were 5.3 days and 15.3 tablets, respectively. Patients expected moderate postoperative pain: mean preoperative VAS = 68.9. The preoperative VAS rating was associated with a significantly greater amount (P = 0.0265) and longer duration (P = 0.0212) of opioid consumption. Baseline opioid users took opioids for twice as long postoperatively (10.0 versus 5.0 days; P = 0.0149) and consumed twice as many tablets (29.3 versus 14.8 tablets; P = 0.0280) compared with opioid-naive patients. DISCUSSION: This study demonstrated on average 15.3 opioid tablets over 5.3 days provided satisfactory pain management after ACLR. Risk factors for increased opioid consumption included preoperative opioid use. |
format | Online Article Text |
id | pubmed-8759619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer |
record_format | MEDLINE/PubMed |
spelling | pubmed-87596192022-01-18 Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction Sayegh, Eli T. Otto, Tracey S. Garvey, Kirsten D. Martin, Anna Lowenstein, Natalie A. Matzkin, Elizabeth G. J Am Acad Orthop Surg Glob Res Rev Research Article INTRODUCTION: The amount and duration of opioids necessary after anterior cruciate ligament reconstruction (ACLR) are inadequately defined. This study sought to prospectively (1) define the amount and duration of opioid consumption, (2) investigate the relationship between preoperative pain expectation and postoperative satisfaction with pain management, and (3) identify risk factors for increased opioid use after ACLR. METHODS: One hundred eight patients undergoing primary ACLR with hamstring graft were prospectively analyzed for preoperative pain expectation, using visual analog scale (VAS) rating, and postoperative satisfaction with pain management. Univariate and multivariate analyses were done to identify patient characteristics associated with satisfaction and/or amount and duration of opioid use. RESULTS: Mean duration and cumulative intake of opioid consumption after ACLR were 5.3 days and 15.3 tablets, respectively. Patients expected moderate postoperative pain: mean preoperative VAS = 68.9. The preoperative VAS rating was associated with a significantly greater amount (P = 0.0265) and longer duration (P = 0.0212) of opioid consumption. Baseline opioid users took opioids for twice as long postoperatively (10.0 versus 5.0 days; P = 0.0149) and consumed twice as many tablets (29.3 versus 14.8 tablets; P = 0.0280) compared with opioid-naive patients. DISCUSSION: This study demonstrated on average 15.3 opioid tablets over 5.3 days provided satisfactory pain management after ACLR. Risk factors for increased opioid consumption included preoperative opioid use. Wolters Kluwer 2022-01-13 /pmc/articles/PMC8759619/ /pubmed/35025832 http://dx.doi.org/10.5435/JAAOSGlobal-D-21-00298 Text en Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Orthopaedic Surgeons. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Sayegh, Eli T. Otto, Tracey S. Garvey, Kirsten D. Martin, Anna Lowenstein, Natalie A. Matzkin, Elizabeth G. Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction |
title | Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction |
title_full | Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction |
title_fullStr | Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction |
title_full_unstemmed | Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction |
title_short | Defining the Opioid Requirement in Anterior Cruciate Ligament Reconstruction |
title_sort | defining the opioid requirement in anterior cruciate ligament reconstruction |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759619/ https://www.ncbi.nlm.nih.gov/pubmed/35025832 http://dx.doi.org/10.5435/JAAOSGlobal-D-21-00298 |
work_keys_str_mv | AT sayeghelit definingtheopioidrequirementinanteriorcruciateligamentreconstruction AT ottotraceys definingtheopioidrequirementinanteriorcruciateligamentreconstruction AT garveykirstend definingtheopioidrequirementinanteriorcruciateligamentreconstruction AT martinanna definingtheopioidrequirementinanteriorcruciateligamentreconstruction AT lowensteinnataliea definingtheopioidrequirementinanteriorcruciateligamentreconstruction AT matzkinelizabethg definingtheopioidrequirementinanteriorcruciateligamentreconstruction |